Study: Covid pill cuts risk of hospitalization and death by 50%

An experimental oral medication reduced the risk of hospitalization and death from covid by 50% in an interim clinical trial. The drug, named molnupiravir, was developed by Merck and Ridgeback Biotherapeutics, who will now proceed immediately to securing emergency use authorization. — Read the rest

from Boing Boing https://ift.tt/3iptTca
via IFTTT

Share on Google Plus

About Unknown

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.